Armata Pharmaceuticals (ARMP) Other Gross PP&E Adjustments (2016 - 2026)
Quarterly results put Other Gross PP&E Adjustments at -$7.1 million for Q1 2026, up 51.53% from a year ago — trailing twelve months through Mar 2026 was -$7.1 million (up 51.53% YoY), and the annual figure for FY2025 was -$9.6 million, up 43.83%.
Armata Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 14 years, most recently at -$7.1 million for Q1 2026.
- Other Gross PP&E Adjustments reached -$7.1 million in Q1 2026 per ARMP's latest filing, up from -$9.6 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$7.1 million in Q1 2026 and bottomed at -$28.3 million in Q4 2022.
- Median Other Gross PP&E Adjustments over the past 5 years was -$19.4 million (2024), compared with a mean of -$18.6 million.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 3108.87% in 2022 before it soared 51.53% in 2026.
- Over 5 years, Other Gross PP&E Adjustments stood at -$28.3 million in 2022, then rose by 20.83% to -$22.4 million in 2023, then increased by 23.71% to -$17.1 million in 2024, then soared by 43.83% to -$9.6 million in 2025, then grew by 25.92% to -$7.1 million in 2026.
- Business Quant data shows Other Gross PP&E Adjustments for ARMP at -$7.1 million in Q1 2026, -$9.6 million in Q4 2025, and -$13.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -7.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.12 Mn |
| Mar 31, 2026 | -7.12 Mn |
| Dec 31, 2025 | -9.61 Mn |
| Dec 31, 2025 | -9.61 Mn |
| Sep 30, 2025 | -13.10 Mn |
| Sep 30, 2025 | -13.10 Mn |
| Jun 30, 2025 | -13.96 Mn |
| Jun 30, 2025 | -13.96 Mn |
| Mar 31, 2025 | -14.68 Mn |
| Mar 31, 2025 | -14.68 Mn |
| Dec 31, 2024 | -17.10 Mn |
| Dec 31, 2024 | -17.10 Mn |
| Sep 30, 2024 | -15.87 Mn |
| Sep 30, 2024 | -15.87 Mn |
| Jun 30, 2024 | -17.74 Mn |
| Jun 30, 2024 | -17.74 Mn |
| Mar 31, 2024 | -19.41 Mn |
| Mar 31, 2024 | -19.41 Mn |
| Dec 31, 2023 | -22.42 Mn |
| Dec 31, 2023 | -22.42 Mn |
| Sep 30, 2023 | -23.87 Mn |
| Sep 30, 2023 | -23.87 Mn |
| Jun 30, 2023 | -23.28 Mn |
| Jun 30, 2023 | -23.28 Mn |
| Mar 31, 2023 | -26.06 Mn |
| Mar 31, 2023 | -26.06 Mn |
| Dec 31, 2022 | -28.32 Mn |
| Dec 31, 2022 | -28.32 Mn |
| Sep 30, 2022 | -19.43 Mn |
| Sep 30, 2022 | -19.43 Mn |
| Jun 30, 2022 | -21.12 Mn |
| Jun 30, 2022 | -21.12 Mn |
| Mar 31, 2022 | -22.72 Mn |
| Mar 31, 2022 | -22.72 Mn |
| Dec 31, 2021 | -25.87 Mn |
| Dec 31, 2021 | -25.87 Mn |
| Sep 30, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.52 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.15 Mn |
| Mar 31, 2021 | 755,000.00 |
| Mar 31, 2021 | 755,000.00 |
| Dec 31, 2020 | -1.78 Mn |
| Dec 31, 2020 | -1.78 Mn |
| Sep 30, 2020 | -139,000.00 |
| Sep 30, 2020 | -139,000.00 |
| Jun 30, 2020 | -238,000.00 |
| Jun 30, 2020 | -238,000.00 |
| Mar 31, 2020 | 8.62 Mn |
| Mar 31, 2020 | 8.62 Mn |
| Dec 31, 2019 | 6.96 Mn |
| Dec 31, 2019 | 6.96 Mn |
| Sep 30, 2019 | 9.36 Mn |
| Sep 30, 2019 | 9.36 Mn |
| Jun 30, 2019 | 10.99 Mn |
| Jun 30, 2019 | 10.99 Mn |
| Mar 31, 2019 | -286,000.00 |
| Mar 31, 2019 | -286,000.00 |
| Dec 31, 2018 | 10.21 Mn |
| Dec 31, 2018 | 10.21 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2016 | 1.21 Mn |
| Dec 31, 2016 | 1.21 Mn |